Biological and biosimilar therapies in inflammatory conditions: challenges for the Central and Eastern European countries

Eur J Health Econ. 2014 May:15 Suppl 1:S1-4. doi: 10.1007/s10198-014-0588-2.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Biosimilar Pharmaceuticals / economics
  • Biosimilar Pharmaceuticals / therapeutic use*
  • Europe
  • Financing, Government
  • Humans
  • Inflammation / drug therapy*
  • Inflammation Mediators / economics
  • Inflammation Mediators / therapeutic use*
  • Reimbursement Mechanisms
  • Technology Assessment, Biomedical

Substances

  • Biosimilar Pharmaceuticals
  • Inflammation Mediators